Company Filing History:
Years Active: 2009-2016
Title: Innovator Maurice Behague: Pioneering Pathogen Inactivation Technologies
Introduction
Maurice Behague, an accomplished inventor based in Linselles, France, has made significant contributions in the field of medical technology. With a portfolio of 4 patents, his work primarily focuses on the development of advanced irradiation apparatuses aimed at inactivating pathogens and leukocytes in biological fluids.
Latest Patents
Among Behague's latest inventions is an innovative irradiation apparatus designed for inactivating pathogens and/or leukocytes in biological fluids, such as platelet suspensions and plasma. This apparatus features a robust casing and a support member that carries an irradiation bag containing the biological fluid. It incorporates a light source composed of two banks of UVC light, strategically placed above and below the support member. Moreover, an agitation system is integrated to move the support member in an orbital path, ensuring that the entire biological fluid is adequately exposed to UVC light of suitable intensity, allowing for effective pathogen and leukocyte inactivation.
Career Highlights
Maurice Behague has worked with notable companies such as Maco Pharma S.A. and Macopharma, where he has sharpened his skills and furthered his innovative ideas in the medical tech industry. His experience and expertise have laid the groundwork for his successful patent portfolio.
Collaborations
Throughout his career, Behague has collaborated with various professionals, including his colleagues Thierry Verpoort and Francis Goudaliez. Together, they have worked towards enhancing medical technologies and improving patient outcomes through innovative solutions.
Conclusion
Maurice Behague continues to be a prominent figure in the field of medical innovation, contributing valuable advancements through his inventions and collaborations. His latest patent work underscores his dedication to improving healthcare technologies and addressing critical challenges in pathogen inactivation.